FLUDARA

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

FLUDARABINE PHOSPHATE 50 MG/VIAL

Tillgänglig från:

SANOFI - AVENTIS ISRAEL LTD

ATC-kod:

L01BB05

Läkemedelsform:

POWDER FOR SOLUTION FOR INJ/INF

Administreringssätt:

I.V

Tillverkad av:

GENZYME EUROPE B.V., NETHERLANDS

Terapeutisk grupp:

FLUDARABINE

Terapeutiska indikationer:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

Tillstånd datum:

2009-02-01